8 completed, 3 recruiting, 3 terminated, 1 withdrawn. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 8, Recruiting 3, Terminated 3, Withdrawn 1 |
Follow sultamicillin: new trials by email Literature Review of sultamicillin trials Research Report on sultamicillin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Options for CRAB Fosfomycin, Eravacycline, ampicillin/sulbactam - Infections, Bacterial, Sepsis Bacterial | Phase 4 | Recruiting | Clinical Hospital Centre Zagreb | 108 | 2025-01-30 | 2026-01-21 |
| Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii Cefiderocol, Ampicillin-sulbactam, Colistin - Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia | Phase 4 | Recruiting | Rambam Health Care Campus | 734 | 2024-09-01 | 2025-08-01 |
| Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP Ampicillin for Injection, Ceftriaxone for Injection, Amoxicillin - Community Acquired Pneumonia in Children | Phase 4 | Recruiting | Medical College of Wisconsin | 236 | 2024-08-22 | 2026-03-02 |
| Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation Ampicillin sulbactam 3 days, Placebo 3 days - Heart Block, CIED Related Infection | Phase 4 | Completed | Universitas Diponegoro | 60 | 2024-04-01 | 2025-02-27 |
| Comparing Oral Versus Parenteral Antimicrobial Therapy Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection | Phase 4 | Terminated | West Virginia University | 94 | 2023-08-04 | 2025-08-26 |
| Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens Ceftriaxone, Ampicillin/sulbactam, Piperacillin/tazobactam - Open Fracture, Post-Op Wound Infection | Phase 4 | Terminated | Mercy Health Ohio | 17 | 2018-07-09 | 2020-09-11 |
| Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD Sultamicillin, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Hannover Medical School | 295 | 2013-06-07 | 2020-06-05 |
| Antibiotic Prophylaxis in Laparoscopic Cholecystectomy Ciprofloxacin, Ampicillin-sulbactam, Placebo - Cholelithiasis | Phase 4 | Terminated | University of Roma La Sapienza | 138 | 2013-06-01 | 2020-03-25 |
| Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients Sultamicillin - Ventilator Associated Pneumonia | Phase 4 | Withdrawn | Hospital Pablo Tobón Uribe | 2011-03-01 | 2016-05-24 | |
| A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections moxifloxacin, ampicillin/sulbactam - Intra-abdominal Infection | Phase 4 | Completed | Kaohsiung Medical University Chung-Ho Memorial Hospital | 100 | 2009-01-01 | 2011-08-02 |
| T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam Ertapenem, Ampicillin-Sulbactam - Intra-Abdominal Infection | Phase 4 | Completed | University of Bologna | 142 | 2008-01-01 | 2011-08-18 |
| Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections Tigecycline, ampicillin-sulbactam - Skin Diseases, Bacterial | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 550 | 2006-09-01 | 2026-09-15 |
| Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section Ampicillin-sulbactam, Cefuroxime - Surgical Site Infections | Phase 4 | Completed | Attikon Hospital | 176 | 2004-07-01 | 2010-06-07 |
| Zithromax EV in Community-Acquired Pneumonia (CAP) Azithromycin, Ampicillin/sulbactam - Pneumonia | Phase 4 | Completed | Pfizer | 151 | 2003-11-01 | 2011-04-22 |
| The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients. Ampicillin/Sulbactam - Breast Cancer | Phase 4 | Completed | Marmara University | 372 | 2003-10-01 | 2013-01-30 |
Intraabdominal Infections (2) · Surgical Wound Infection (2) · Bacterial Infections (1) · Brain Injuries (1) · Breast Neoplasms (1) · Cellulitis (1) · Cholelithiasis (1) · Coma (1) · Community-Acquired Pneumonia (1) · Fractures, Open (1) · Heart Block (1) · Infections (1) · Overweight (1) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1)
Attikon Hospital (1) · Clinical Hospital Centre Zagreb (1) · Hannover Medical School (1) · Hospital Pablo Tobón Uribe (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Marmara University (1) · Medical College of Wisconsin (1) · Mercy Health Ohio (1) · Pfizer (1) · Rambam Health Care Campus (1) · Universitas Diponegoro (1) · University of Bologna (1) · University of Roma La Sapienza (1) · West Virginia University (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (4) · Israel (2) · Italy (2) · Taiwan (2) · Canada (1) · Colombia (1) · Croatia (1) · Germany (1) · Hong Kong (1) · Indonesia (1) · Lebanon (1) · Malaysia (1) · Philippines (1) · Singapore (1) · South Africa (1)
Allison R Lauver, PharmD (1) · Antonio Daniele Pinna, MD (1) · Arif R. Sarwari, MD, MSc, MBA (1) · Bahadir M Gulluoglu, MD, FACS (1) · Carlos A Cadavid, MD (1) · Chad W Donley, MD (1) · Cristina Puggioli, MD (1) · Dafna Yahav (1) · David J Gemmel, PhD (1) · Erasmo Spaziani, MD, PhD (1) · Fausto Catena, MD PhD (1) · Gernot Rohde, Prof. Dr. (1) · Giorgio Ercolani, MD (1) · Joy J. Juskowich, MD (1)
PMID 21118502, PMID 21501482, PMID 23001082, PMID 23145952, PMID 23631512, PMID 25623589, PMID 29456043, PMID 33661539, PMID 41419216